Company Search:
Advanced Search
Sponsored Links
Sol SpA Company Snapshot
Sol SpA operates in the Home health care services sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sol SpA with three other health care providers in Europe: Ambea Ab (Publ) of SWEDEN (2019 sales of 11.04 billion Swedish Kronor [US$1.30 billion] of which 33% was Nytida), Humana AB of SWEDEN (7.47 billion Swedish Kronor [US$879.02 million] of which 37% was Personal Assistance), and Aevis Victoria SA which is based in SWITZERLAND (844.85 million Swiss Francs [US$930.44 million] of which 63% was Hospitals).

Sales Analysis. Sol SpA reported sales of 904.31 million Euro (US$1.08 billion) for the year ending December of 2019. This represents an increase of 8.5% versus 2018, when the company's sales were 833.51 million Euro. Sales at Sol SpA have increased during each of the previous five years (and since 2014, sales have increased a total of 42%). Sales of Homecare saw an increase of 14.3% in 2019, from 431.33 million Euro to 492.89 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sol SpA
  Stock Performance Chart for Sol SpA
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 12.50
(Figures in Euros )
1 Week 1.2%   13 Weeks 7.8%  
4 Weeks 14.2%   52 Weeks 21.4%  
Sol SpA Key Data:
  Ticker: SOL Country: Italy
  Exchanges: ISE Major Industry: Health Care Equipment & Services
    Sub Industry: Home Health Care Services
  2019 Sales 904,313,000
(Year Ending Jan 2020).
Employees: 4,320
  Currency: Euros Market Cap: 1,133,750,000
  Fiscal Yr Ends: December Shares Outstanding: 90,700,000
  Share Type: Azioni Ordinarie Closely Held Shares: 61,199,825
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.